Toggle navigation
Home
Search
Services
Blog
Contact
About
Production of A Recombinant H5 N1 Vaccine for Phase 1
Smith, Gail
Protein Sciences Corporation, Meriden, CT, United States
Search 21 grants from Gail Smith
Search grants from Protein Sciences Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Pathogenesis of Tick-Borne Flavivirus Infections
Neurocognitive Rehabilitation in Alcohol Treatment
Snuff carcinogenesis in the oral cavity
Smooth Muscle Cell Differentiation in Vitro and IN Vivo
The IN Vitro and IN Vivo Regulation of Hemopoiesis
Recently added grants:
Transcriptional regulators of iris muscle cell development
OCT in the Ocular Hypertension Treatment Study: 20 Year Follow-up
Iron and Diabetic Retinopathy
Roles for Mismatch Repair Proteins in Maintaining Genome Stability
C. elegans gastrulation: A model for understanding apical constriction mechanisms
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI085333-000
Application #
2711335
Study Section
Project Start
1997-12-19
Project End
Budget Start
1997-12-19
Budget End
1998-04-18
Support Year
Fiscal Year
1998
Total Cost
Indirect Cost
Institution
Name
Protein Sciences Corporation
Department
Type
DUNS #
City
Meriden
State
CT
Country
United States
Zip Code
06450
Related projects
NIH 1998
N01 AI
Production of A Recombinant H5 N1 Vaccine for Phase 1
Smith, Gail / Protein Sciences Corporation
NIH 1998
N01 AI
Production of A Recombinant H5 N1 Vaccine for Phase 1
Smith, Gail / Protein Sciences Corporation
Comments
Be the first to comment on this grant